ADX-324 Dose Level 1 clinical trials

Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)

This study is an extension of a previous trial for people with a condition called hereditary angioedema (HAE). It's looking at the long-term safety and how well a medicine, ADX-324, works for HAE types 1 and 2. Participants would have already taken part in the earlier study.